214 related articles for article (PubMed ID: 25678471)
1. Interferon-α induces altered transitional B cell signaling and function in Systemic Lupus Erythematosus.
Chang NH; Li TT; Kim JJ; Landolt-Marticorena C; Fortin PR; Gladman DD; Urowitz MB; Wither JE
J Autoimmun; 2015 Apr; 58():100-10. PubMed ID: 25678471
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
[TBL] [Abstract][Full Text] [Related]
3. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
[TBL] [Abstract][Full Text] [Related]
4. B-cell subsets, signaling and their roles in secretion of autoantibodies.
Iwata S; Tanaka Y
Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
6. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients.
Liu M; Guo Q; Wu C; Sterlin D; Goswami S; Zhang Y; Li T; Bao C; Shen N; Fu Q; Zhang X
Cell Mol Immunol; 2019 Apr; 16(4):367-379. PubMed ID: 29563616
[TBL] [Abstract][Full Text] [Related]
7. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.
Enyedy EJ; Nambiar MP; Liossis SN; Dennis G; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 May; 44(5):1114-21. PubMed ID: 11352243
[TBL] [Abstract][Full Text] [Related]
8. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.
Vásquez A; Baena A; González LA; Restrepo M; Muñoz CH; Vanegas-García A; Ortiz-Reyes B; Abdoel N; Rojas M; García LF; Vásquez G
Cell Signal; 2019 Jun; 58():9-19. PubMed ID: 30840855
[TBL] [Abstract][Full Text] [Related]
9. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients.
Rodríguez-Bayona B; Ramos-Amaya A; Pérez-Venegas JJ; Rodríguez C; Brieva JA
Arthritis Res Ther; 2010; 12(3):R108. PubMed ID: 20525218
[TBL] [Abstract][Full Text] [Related]
10. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.
Wu XN; Ye YX; Niu JW; Li Y; Li X; You X; Chen H; Zhao LD; Zeng XF; Zhang FC; Tang FL; He W; Cao XT; Zhang X; Lipsky PE
Sci Transl Med; 2014 Jul; 6(246):246ra99. PubMed ID: 25101889
[TBL] [Abstract][Full Text] [Related]
11. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphorylation and kinome profiling reveal altered regulation of multiple signaling pathways in B lymphocytes from patients with systemic lupus erythematosus.
Taher TE; Parikh K; Flores-Borja F; Mletzko S; Isenberg DA; Peppelenbosch MP; Mageed RA
Arthritis Rheum; 2010 Aug; 62(8):2412-23. PubMed ID: 20506108
[TBL] [Abstract][Full Text] [Related]
13. Interferon
Akita K; Yasaka K; Shirai T; Ishii T; Harigae H; Fujii H
Front Immunol; 2020; 11():498703. PubMed ID: 33633721
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
Hillion S; Garaud S; Devauchelle V; Bordron A; Berthou C; Youinou P; Jamin C
Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
[TBL] [Abstract][Full Text] [Related]
15. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
[TBL] [Abstract][Full Text] [Related]
16. Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases.
Ghosh D; Tsokos GC
Autoimmunity; 2010 Feb; 43(1):48-55. PubMed ID: 20001666
[TBL] [Abstract][Full Text] [Related]
17. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins.
Feuerstein N; Chen F; Madaio M; Maldonado M; Eisenberg RA
J Immunol; 1999 Nov; 163(10):5287-97. PubMed ID: 10553051
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation.
Carsetti L; Laurenti L; Gobessi S; Longo PG; Leone G; Efremov DG
Cell Signal; 2009 Jul; 21(7):1187-94. PubMed ID: 19296913
[TBL] [Abstract][Full Text] [Related]
19. Expanded population of activated antigen-engaged cells within the naive B cell compartment of patients with systemic lupus erythematosus.
Chang NH; McKenzie T; Bonventi G; Landolt-Marticorena C; Fortin PR; Gladman D; Urowitz M; Wither JE
J Immunol; 2008 Jan; 180(2):1276-84. PubMed ID: 18178868
[TBL] [Abstract][Full Text] [Related]
20. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments.
Liossis SN; Melissaropoulos K
Expert Opin Pharmacother; 2014 Apr; 15(6):833-40. PubMed ID: 24588739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
